We collaborate with patient advocacy platforms to promote quality medical care and services and to improve and expand educational and outreach efforts.
It is our mission to discover, develop and deliver innovative therapies that help to improve patients' quality of life.
Our product portfolio focuses on innovation in new products, improved products and manufacturing expertise.
We are committed to helping improve the quality of life for those who use our therapies.
CSL Behring provides a wide range of treatments for people with rare or life-threatening illnesses.
Christian Wieszner appointed UK General Manager
Christian will be based at CSL Behring’s UK headquarters in Haywards Heath, West Sussex.
Rhesus disease explained
Babies inherit their blood type from their parents, but when the child’s blood type isn’t compatible with the mother’s, it ca…
Why Sit It Out? campaign wins healthcare communications award
The Why Sit It Out? campaign has won a prestigious Communique award for excellence in communications.
Diversity: Good for our people and patients
When you work at a leading global biotech company with more than 27,000 employees, serving patients in more than 100 countrie…
Research is tough, success is stupendous
Andrew Nash, CSL’s Chief Scientific Officer, is a busy man. He has his arms around 25 or 30 ongoing research projects spannin…
Introducing Emil von Behring
The scientist who put the ‘Behring’ into CSL Behring won the first Nobel Prize for medicine.
Popular search terms:
Americas
Asia Pacific
Europe
This website uses cookies to ensure the best possible user experience.
Please note that if you do not accept the cookies, your user experience may be significantly less positive.
You will find more information on how to disable the use of cookies in our Privacy Notice.
